Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics
Seer's new Proteograph ONE Assay to accelerate analysis and reduce costs, making large-scale studies feasible
REDWOOD CITY, Calif., June 01, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, and Korea University, a leading research institution committed to innovation and global impact, today announced the launch of a population-level study aimed at identifying novel blood-based biomarkers that could lead to cancer diagnostics for young adults in their 20s and 30s. Relying on Seer's newly launched Proteograph® ONE Assay and SP200 Automation Instrument along with the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer, this is the first large-scale plasma proteomics initiative of its kind to leverage mass spectrometry and AI-driven analytics to enhance early cancer detection and improve patient outcomes.
Seer's latest platform advances will allow deep, unbiased proteomic analysis of 20,000 plasma samples in less time and cost than has ever before been possible. These will include samples from 15,000 cancer patients and 5,000 healthy patients that will serve as controls, sourced from Korea's leading cancer institutions: Seoul National University Hospital, the National Cancer Center, and Samsung Medical Center. The three-year study is funded by the K-Health MIRAE initiative under the Ministry of Health and Welfare, Republic of Korea, which supports ambitious, high-impact health research.
'We carefully evaluated multiple approaches to expand the dynamic range of the plasma proteome—including some attempting to replicate Seer's Proteograph platform—and Seer's assay stood out as the only solution capable of delivering the depth, scale, and, critically, reproducibility needed for this ambitious study,' said Professor Sang-Won Lee at the Center of Proteogenome Research (CPGR) of Korea University. 'The unique combination of Seer's latest platform and CPGR's proprietary dual online liquid chromatography technology gives us the ability to conduct population-scale research that would otherwise be prohibitively complex and slow. This collaboration represents a major step toward developing AI-powered diagnostics that could fundamentally improve how we detect and treat cancer in younger adults.'
By leveraging the power of deep proteomic analysis, this study aims to catalyze a new wave of diagnostics that are more sensitive, scalable, and personalized—ultimately driving earlier interventions and improving survival outcomes in young adult cancer patients worldwide.
Transformational Technology for Population-Scale Proteomics
At the heart of the study is Seer's Proteograph ONE workflow, introduced this week at the 2025 American Society for Mass Spectrometry (ASMS) Conference in Baltimore, MD. The next-generation system dramatically increases scale and efficiency in proteomic analysis by:
'Korea University selected Seer's new Proteograph ONE workflow as the foundation for this critical and forward-looking initiative so that they can unlock the full potential of proteomics in population-scale research,' said Omid Farokhzad, Chair and CEO of Seer. 'We're excited to help define a new generation of diagnostics that can transform how diseases like cancer are detected and managed around the world.'
The study also employs Thermo Scientific's Orbitrap Astral MS—the industry's leading mass spectrometer for proteomic research. The Proteograph offerings combined with the Orbitrap Astral MS provide a deep, full-range plasma proteome analysis at faster speeds to enable critical breakthrough discoveries in large-population studies.
'When it comes to plasma proteomics studies such as this, the Orbitrap Astral MS and Proteograph ONE workflow provide a powerful solution to drive groundbreaking research,' said Dan Shine, senior vice president and president of analytical instruments, Thermo Fisher Scientific. 'We're proud to be a part of initiatives like this to enable earlier detection and help progress precision medicine.'
The next-generation offerings mark a significant evolution of the Proteograph Product Suite, delivering the scale, speed, and efficiency required to make population-level proteomics both practical and accessible. The collaboration with Korea University exemplifies the real-world impact of this technology—demonstrating how deep, unbiased proteomic insights powered by Seer's platform can now inform large-scale studies, accelerate biomarker discovery, and drive the development of AI-enabled diagnostics that redefine precision medicine.
About Seer, Inc.
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with a scale, speed, precision, and reproducibility previously unattainable. Seer's Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer's robust and scalable workflow consistently reveals biological insights that others cannot. Seer's products are for research use only and are not intended for diagnostic procedures. For more information about Seer's differentiated approach and ongoing leadership in proteomics, visit www.seer.bio.
Media Contact:
Consort Partners
[email protected]
Investor Contact:
Carrie Mendivil
[email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
16 minutes ago
- CBS News
Pennsylvania family who stayed at Ronald McDonald house shares their continued message of hope
Bucks County family who stayed at the Ronald McDonald house shares their continued message of hope Bucks County family who stayed at the Ronald McDonald house shares their continued message of hope Bucks County family who stayed at the Ronald McDonald house shares their continued message of hope "Sarah's Painting" was created in a hospital bed by a 9-year-old going through chemotherapy. Michael Pulaski said his daughter, Sarah, loved to paint. "Which was kind of news to us, and she was actually pretty good!" Michael Pulaski said with a chuckle and smile. "It meant something to her, so it meant something to us." Now this picture is taking on a bigger meaning. "Sarah's Painting" CBS News Philadelphia. "It's been, for years, my method of communicating with the world," Sarah's brother, Ryan Pulaski, said. The 22-year-old college student is in the process of making an album. His first single was released Friday, on what would be Sarah's 25th birthday. "In Sarah's Painting, I see visions of life it should be," he sings in the song called "Sarah's Painting." It's inspired by the colorful brush strokes frozen in time. "I feel exceptionally called to create art, and it is only because I had, I have this wonderful sister who was an artist herself, that I was able to find my own voice," Ryan Pulaski said. Pulaski family. In 2010, CBS News Philadelphia caught Sarah's infectious smile on camera while walking the halls of the Children's Hospital of Philadelphia. She talked with us about a Ronald McDonald house family room for the telethon. "When we first met you, it was actually a stressful but promising time, because Sarah was in her first portions of treatment, and she was doing well," Michael Pulaski said. The pre-teen from Richboro went into remission, but later relapsed. At 11 years old, she died after a brave, long battle with leukemia. "This is my absolute favorite picture of the two of them together," Michael Pulaski said, pointing at a photo of Ryan and Sarah. Pulaski family. It's an unbreakable sibling bond — shining through photos, "Sarah's Painting," and now Ryan's song. "She'd probably tell me, I still can't sing," Ryan Pulaski said with a laugh. He continued, "But I think she would love it and be supportive all the same." As for the sibling's dad, "There aren't words, and I'm just proud." The Pulaski family said this story — it's one full of hope, to show others, a picture is worth a thousand words, a thousand memories and a love that lasts a thousand lifetimes. "I think if my 22-year-old son, who's had a probably a more difficult journey than I have, can find hope and joy, then I think the rest of us can too," Michael Pulaski said.
Yahoo
an hour ago
- Yahoo
Skull Discovered in 1933 Sheds Light on Ancient Human Species
Two new studies published in Science and Cell have shed light on a mysterious skull found in China, and in the process have provided insight into the lives of a previously little-known ancient human. The 'Dragon Man' skull was found in Harbin City, China, during an excavation in 1933. The skull, which was terrifically well-preserved, was kept by the discovering archaeologist because he feared authorities would confiscate the skull. In 2018, shortly before he died, the archaeologist donated the skull for analysis. The Dragon Man's skull was much larger than modern humans, bearing an expanded brain volume as well as deep, prominent eyebrow ridges, a flat face, a wide nose, and no chin. Scientists estimated that the person lived roughly 146,000 years ago. After studying molecules from a molar in the skull, Qiaomei Fu, a geneticist at Beijing's Institute of Vertebrate Paleontology and Paleoanthropology, determined that it likely belonged to a Denisovan. Denisovans have long been a mystery to scientists, as they only had the pinkie bone of an adolescent, which was discovered in 2010 and rumor genes fitfully present in modern humans available to study. Though DNA has long shown that Denisovans were interbred with Neandertals and modern humans, with as much as five percent of their genetic composition existing in people from Melanesia and other Southeast Asian regions, this is the first Denisovan skull which has been discovered. 'After 15 years, we give the Denisovan a face,' Fu told National Geographic. 'It's really a special feeling, I feel really happy.' In their study published in Cell, the researchers added: "This is the first detailed morphological blueprint for Denisovan populations.' The discovery redefines the history of human evolution in South Asia, with researchers now able to investigate how the Denisovans' contributions to ancient culture still reverberate in the modern day. "Having a well-preserved skull like this one allows us to compare the Denisovans to many more different specimens found in very different places,' Bence Viola, an archaeologist not involved with the study, told New Scientist. 'We can finally think about their adaptations to climate, mobility, and even social behavior.' Skull Discovered in 1933 Sheds Light on Ancient Human Species first appeared on Men's Journal on Jun 20, 2025
Yahoo
an hour ago
- Yahoo
Why India's Budding EV Sector Has Opened Its Doors To China
For decades, China has driven the lion's share of oil demand growth thanks to its remarkable economic boom and large population. However, China is now losing its prominence in global oil markets due to a dramatic slowdown in its economy coupled with the country's ongoing electric vehicle revolution. Last year, nearly half of all new cars sold in China were electric vehicles, including both battery-electric and plug-in hybrid electric vehicles. Indeed, China's rapid adoption of EVs, as well as rapid growth of high-speed rail and natural gas trucks, is displacing traditional fossil fuel demand, with the International Energy Agency (IEA) predicting that China's oil demand will peak as early as 2027. Ironically, the country that is taking over China's mantle in world oil markets is also aspiring to follow in its EV footsteps: India. Unlike China, India's EV sector is still at its infancy, with electric vehicles accounting for just 2.5% of all cars sold in the country in 2024. However, India has big EV ambitions, with the Indian government having set a target for EVs to make up 30% of total passenger vehicle sales by 2030. To accomplish this, India's EV sector is forging close ties with Chinese EV manufacturers at a time when Washington has been keeping Chinese EV giants at bay. India is relying on Chinese EV tech to bridge the gap until the domestic sector is ready to compete on the global stage. Industry analysts note that without access to Chinese technologies—including batteries, drivetrain components, and EV software—India would likely face slower product rollouts, limited model variety, and higher costs during its growth phase. This marks a clear pivot from just a few years ago, when India restricted the operations of firms like BYD and banned popular Chinese apps such as TikTok and Shein after deadly clashes at the New Delhi appears to be taking a more calculated stance. In March, the government reduced tariffs on over 35 EV components, many of which are imported from China, making it easier for automakers to source critical parts. A few weeks later, India's Ministry of Heavy Industries unveiled a new EV policy slashing import duties on fully built EVs from 110% to 15%, provided manufacturers invest and set up local production. This dual-pronged approach aims to attract international players while building out domestic supply chains. Experts view these shifts as pragmatic. Leading Indian EV makers—such as Tata Motors, Ola Electric, and Mahindra & Mahindra—continue to depend on Chinese vendors for components like battery cells, power control units, and electric motors, even though assembly is carried out in India. 'The aim is to build a resilient domestic ecosystem, not to isolate it, unlike the more aggressive decoupling seen in the U.S. with China,' said Shubham Munde, senior analyst at intelligence firm Market Research Future. Yet this growing alignment between Indian and Chinese EV sectors is creating both opportunity and competition. MG Motor—a joint venture between India's JSW Group and China's state-owned automaker SAIC—has managed to double its market share over the past year, putting pressure on homegrown giants like Tata Motors. Its model, the MG Windsor, is now India's top-selling electric car, highlighting how joint ventures are gaining traction. At the same time, India's EV landscape remains deeply fragmented. According to Bernstein Research, just four legacy automakers dominate 80% of the electric mobility market, leaving over 150 EV startups struggling to establish a foothold in an increasingly competitive space. Government policy appears to be playing an outsized role in the EV trajectories of different countries. In its 2025 Electric Vehicles Outlook, Bloomberg New Energy Finance (BNEF) cut both its near-term and long-term passenger EV adoption outlook in the United States for the first time ever, citing key policy changes including rollback of national fuel-economy targets as well as the removal of supportive elements of the Inflation Reduction Act (IRA) by the Trump administration. In contrast, S&P Global Mobility has forecast strong growth for India's nascent EV sector, projecting that production of battery-electric passenger vehicles will increase by 140% year-over-year in 2025 to roughly 301,400 units. That would represent about 6% of the estimated 5.16 million passenger vehicles expected to be built in India that year. Still, the road to India's 2030 goal may be steep. According to S&P, India would need to boost EV adoption by approximately 380 basis points annually to reach 30% market share—nearly double the current growth rate of around 200 basis points per year since 2021. Compounding the challenge is the lack of a unified long-term roadmap and the pending expiration of several state-level EV incentive programs. By Alex Kimani for More Top Reads From this article on Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
